Compare Nasdaq100 ETF (QQQ) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nasdaq100 ETF vs Twist Bioscience Corp — how do they compare? Nasdaq100 ETF trades at $714.77, while Twist Bioscience Corp trades at $125.52 (market cap $8.26B). Which is the better fit depends on your goals.
| QQQ | TWST | |
|---|---|---|
52-Week High | $746.16 | $153.10 |
52-Week Low | $558.34 | $24.16 |
Market Cap | — | $8.26B |
Sector | — | Health |
Enterprise Value | — | $8.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QQQ trades at $718.36, down slightly by 0.08% on the day, with a bullish technical outlook from moving averages and neutral oscillators. Support levels are at $715 and $712, with resistance at $722 and $725. Analyst sentiment is split evenly between buy and sell recommendations, reflecting uncertainty amid mixed news coverage.
The ETF's outlook is supported by strong historical performance and growth exposure, but risks include fee competitiveness and market volatility. Investors should weigh the divided analyst consensus against the fund's track record in technology and growth sectors.
Twist Bioscience (TWST) trades at $128.06, up 2.68% with a bearish technical signal despite recent AI-driven momentum. The company shows strong revenue growth (2025: $377M, 2026: $432M projected) but continues to report significant losses with negative net margins. Recent news highlights AI partnerships and a $300M stock offering, while analyst consensus remains predominantly bullish with 78.6% buy ratings.
TWST presents a high-risk growth opportunity with accelerating revenue but persistent profitability challenges. The stock's valuation appears stretched at P/S of 18.09, requiring successful execution on AI initiatives and path to EBITDA breakeven. Key risks include cash burn, competitive pressures, and dependence on emerging AI-driven drug discovery markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nasdaq100 ETF
The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on QQQ →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
